{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:10:47Z","timestamp":1779394247156,"version":"3.53.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Antimicrobial resistance (AMR) in <jats:italic>Neisseria gonorrhoeae<\/jats:italic> (NG), compromising gonorrhea treatment, is a global public health concern. Improved, quality-assured NG AMR monitoring at the global level is essential. This mini-review examined NG AMR susceptibility surveillance and AMR data from the African continent from 2001 to 2020. Eligible peer-reviewed publications (n\u2009=\u200930) containing NG AMR data for antimicrobials currently recommended for gonorrhea treatment were included. Overall, very limited NG surveillance and AMR data was available. Furthermore, the NG AMR surveillance studies varied greatly regarding surveillance protocols (e.g., populations and samples tested, sample size, antimicrobials examined), methodologies (e.g., antimicrobial susceptibility testing method [agar dilution, minimum inhibitory concentration (MIC) gradient strip test, disc diffusion test] and interpretative criteria), and quality assurance (internal quality controls, external quality assessments [EQA], and verification of AMR detected). Moreover, most studies examined a suboptimal number of NG isolates, i.e., less than the WHO Global Gonococcal Antimicrobial Surveillance Program (GASP) and WHO Enhanced GASP (EGASP) recommendations of \u2265100 isolates per setting and year. The notable inter-study variability and frequently small sample sizes make appropriate inter-study and inter-country comparisons of AMR data difficult. In conclusion, it is imperative to establish an enhanced, standardized and quality-assured NG AMR surveillance, ideally including patient metadata and genome sequencing as in WHO EGASP, in Africa, the region with the highest gonorrhea incidence globally. This will enable the monitoring of AMR trends, detection of emerging AMR, and timely refinements of national and international gonorrhea treatment guidelines. To achieve this aim, national and international leadership, political and financial commitments are imperative.<\/jats:p>","DOI":"10.3389\/fmicb.2023.1148817","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T05:32:05Z","timestamp":1680759125000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review"],"prefix":"10.3389","volume":"14","author":[{"given":"Francis","family":"Kakooza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Kiggundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Mboowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick David","family":"Kateete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Tendo","family":"Nsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jupiter Marina","family":"Kabahita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ssentalo Bagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-2247-4","article-title":"Neisseria gonorrhoeae among suspects of sexually transmitted infection in Gambella hospital, Ethiopia: risk factors and drug resistance","volume":"9","author":"Ali","year":"2016","journal-title":"BMC. Res. Notes"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/OLQ.0b013e3181982e3c","article-title":"Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated from patients attending a STD facility in Maputo, Mozambique","volume":"36","author":"Apalata","year":"2009","journal-title":"Sex. Transm. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e000518","DOI":"10.1136\/bmjgh-2017-000518","article-title":"Antimicrobial resistance and universal health coverage","volume":"2","author":"Bloom","year":"2017","journal-title":"BMJ Glob. Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007","volume":"37","author":"Brown","year":"2010","journal-title":"Sex. Transm. Dis."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/OLQ.0b013e31818318d8","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaound\u00e9, Cameroon; Antananarivo, Madagascar; and ho chi minh Ville and Nha Trang, Vietnam","volume":"35","author":"Cao","year":"2008","journal-title":"Sex. Transm. Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/0956462419897227","article-title":"Sharp increase in ciprofloxacin resistance of Neisseria gonorrhoeae in Yaounde, Cameroon: analyses of a laboratory database period 2012-2018","volume":"31","author":"Crucitti","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1258\/095646207782193768","article-title":"Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa\u2014implications for treatment guidelines","volume":"18","author":"De Jongh","year":"2007","journal-title":"Int. J. Std Aids"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","article-title":"Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae","volume":"17","author":"Don\u00e0","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7205\/MILMED-D-13-00418","article-title":"Gonorrhea surveillance in Ghana, Africa","volume":"180","author":"Duplessis","year":"2015","journal-title":"Mil. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0956462419886775","article-title":"2018 UK national guideline for the management of infection with Neisseria gonorrhoeae","volume":"31","author":"Fifer","year":"2020","journal-title":"Int. J. Std Aids"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14737159.2022.2015329","article-title":"Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects","volume":"22","author":"Golparian","year":"2022","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref12","first-page":"10","article-title":"Prevalence of Neisseria gonorrhea and their antimicrobial susceptibility patterns among symptomatic women attending gynecology outpatient department in Hawassa referral hospital, Hawassa, Ethiopia","volume":"23","author":"Hailemariam","year":"2013","journal-title":"Ethiop. J. Health Sci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"iv24","DOI":"10.1136\/sextrans-2013-051166","article-title":"Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme","volume":"89","author":"Han\u00e7ali","year":"2013","journal-title":"Sex. Transm. Infect."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1473-3099(18)30225-1","article-title":"Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey","volume":"18","author":"Harris","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e-01479","DOI":"10.1128\/AAC.01479-19","article-title":"High in vitro susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical Neisseria gonorrhoeae isolates from Thailand and South Africa (2015-2017)","volume":"63","author":"Jacobsson","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/sextrans-2020-054581","article-title":"Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda","volume":"97","author":"Kakooza","year":"2021","journal-title":"Sex. Transm. Infect."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/antibiotics7030058","article-title":"Trends in Neisseria gonorrhoeae antimicrobial resistance over a ten-year surveillance period, Johannesburg, South Africa, 2008\u20132017","volume":"7","author":"Kularatne","year":"2018","journal-title":"Antibiotics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/OLQ.0b013e318248a85f","article-title":"Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya","volume":"39","author":"Lagace-Wiens","year":"2012","journal-title":"Sex. Transm. Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/sextrans-2016-053090","article-title":"Antimicrobial susceptibility in Neisseria gonorrhoeae isolates from five sentinel surveillance sites in Zimbabwe, 2015\u20132016","volume":"94","author":"Latif","year":"2018","journal-title":"Sex. Transm. Infect."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/sti.2007.029611","article-title":"Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two south African cities: association with HIV seropositivity","volume":"84","author":"Lewis","year":"2008","journal-title":"Sex. Transm. Infect."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/0956462418799017","article-title":"Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study","volume":"30","author":"Mabonga","year":"2019","journal-title":"Int. J. Std Aids"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00906-20","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae isolates from high-risk men in Johannesburg, South Africa","volume":"64","author":"Maduna","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1128\/AAC.00155-11","article-title":"Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009","volume":"55","author":"Mehta","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/01.olq.0000194581.02022.f0","article-title":"Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa","volume":"33","author":"Moodley","year":"2006","journal-title":"Sex. Transm. Dis."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13104-017-2584-y","article-title":"Bacterial agents and antibiotic resistance profiles of infections from different sites that occurred among patients at Debre Markos referral hospital, Ethiopia: a cross-sectional study","volume":"10","author":"Mulu","year":"2017","journal-title":"BMC. Res. Notes"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12905-015-0197-y","article-title":"Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral hospital, Ethiopia: a cross sectional study","volume":"15","author":"Mulu","year":"2015","journal-title":"BMC Womens Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/0956462419881087","article-title":"Antimicrobial resistance patterns in Neisseria gonorrhoeae among male clients of a sexually transmitted infections clinic in Kisumu, Kenya","volume":"31","author":"Nacht","year":"2020","journal-title":"Int. J. Std Aids"},{"key":"ref28","author":"O\u2019Neill","year":"2016"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e000636","DOI":"10.1136\/bmjopen-2011-000636","article-title":"Phenotypic and genetic characterisation of bacterial sexually transmitted infections in Bissau, Guinea-Bissau, West Africa: a prospective cohort study","volume":"2","author":"Olsen","year":"2012","journal-title":"BMJ Open"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/ejhpharm-2016-001013","article-title":"O\u2019Neill report on antimicrobial resistance: funding for antimicrobial specialists should be improved","volume":"23","author":"Price","year":"2016","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/OLQ.0000000000000961","article-title":"Resistance profile of Neisseria gonorrhoeae in KwaZulu-Natal, South Africa questioning the effect of the currently advocated dual therapy","volume":"46","author":"Rambaran","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/S2666-5247(22)00044-1","article-title":"Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study","volume":"3","author":"S\u00e1nchez-Bus\u00f3","year":"2022","journal-title":"Lancet Microbe."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.12688\/wellcomeopenres.12527.1","article-title":"AMR surveillance in low and middle-income settings\u2013a roadmap for participation in the global antimicrobial surveillance system (GLASS)","volume":"2","author":"Seale","year":"2017","journal-title":"Wellcome Open Res."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's treatment guidelines for Gonococcal infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/OLQ.0000000000000204","article-title":"Etiology and antimicrobial susceptibility of pathogens responsible for urethral discharge among men in Harare, Zimbabwe","volume":"41","author":"Takuva","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1097\/OLQ.0000000000000915","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Yaound\u00e9, Cameroon from 2009 to 2014","volume":"45","author":"Tayimetha","year":"2018","journal-title":"Sex. Transm. Dis."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e1480","DOI":"10.1016\/S2214-109X(19)30362-6","article-title":"Universal health coverage: an opportunity to address antimicrobial resistance? Lancet glob","volume":"7","author":"Tayler","year":"2019","journal-title":"Health"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/hs.2014.0088","article-title":"Antimicrobial resistance is a global health emergency","volume":"13","author":"Toner","year":"2015","journal-title":"Health Secur"},{"key":"ref40","year":"2022"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhoea\u2014the rapidly evolving Neisseria gonorrhoeae continues to challenge","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1093\/jac\/dkw288","article-title":"The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization","volume":"71","author":"Unemo","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1071\/SH19023","article-title":"World health organization global Gonococcal antimicrobial surveillance program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts","volume":"16","author":"Unemo","year":"","journal-title":"Sex. Health"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: a retrospective observational study","volume":"2","author":"Unemo","year":"2021","journal-title":"Lancet Microbe."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"956462420949126","DOI":"10.1177\/0956462420949126","article-title":"European guideline for the diagnosis and treatment of gonorrhoea in adults","volume":"2020","author":"Unemo","year":"2020","journal-title":"Int. J. Std Aids"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"Unemo","year":"","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/OLQ.0000000000000099","article-title":"High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009)","volume":"41","author":"Vandepitte","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/IJWH.S13427","article-title":"Gonorrhea infection in women: prevalence, effects, screening, and management","volume":"3","author":"Walker","year":"2011","journal-title":"Int. J. Womens Health"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e17009","DOI":"10.2196\/17009","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae in a newly implemented surveillance program in Uganda: surveillance report","volume":"6","author":"Workneh","year":"2020","journal-title":"JMIR Public Health Surveill."},{"key":"ref52","year":"2012"},{"key":"ref53","year":"2014"},{"key":"ref54","year":"2016"},{"key":"ref55","year":"2021"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/OLQ.0000000000000943","article-title":"Establishment of a gonococcal antimicrobial surveillance programme, in accordance with World Health Organization standards, in C\u00f4te d\u2019Ivoire, West Africa, 2014-2017","volume":"46","author":"Y\u00e9o","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13756-018-0376-3","article-title":"Neisseria gonorrhoeae and their antimicrobial susceptibility patterns among symptomatic patients from Gondar town, north West Ethiopia","volume":"7","author":"Yeshanew","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1148817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T05:32:09Z","timestamp":1680759129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1148817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":57,"alternative-id":["10.3389\/fmicb.2023.1148817"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1148817","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"article-number":"1148817"}}